GBB Maintains Strong Position in its Ongoing Lawsuit with FSD Pharma After Court Refuses to Dismiss Case
FSD Pharma Inc. - Class B Subordinate Voting Shares (HUGE)
Company Research
Source: GlobeNewswire
WESTON, Fla., Jan. 11, 2024 (GLOBE NEWSWIRE) -- GBB Drink Lab. Inc (“GBB” or the “Company”), a maker of the world’s first rapid blood alcohol detoxification beverage, is pleased to announce that a federal court has refused to dismiss the Company’s ongoing lawsuit against FSD Pharma. FSD Pharma (NASDAQ: HUGE), a clinical-stage biotech company, has violated a Non-Disclosure Agreement (NDA) with GBB and has breached the contract by attempting to steal information and launch GBB’s product without permission. "Nowhere in the Amended Complaint does Plaintiff allege that all nineteen of the ingredients are necessary to create a parallel program or competitor drink, and this Court sees no reason to impose such a requirement. It is apparent, at least to this Court, that Plaintiff takes issue with Defendants’ development of a competing drink, which relies on most of the same ingredients (and methods for combining such ingredients) as Plaintiff’s proprietary beverage,” said the Court. The C
Show less
Read more
Impact Snapshot
Event Time:
HUGE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
HUGE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
HUGE alerts
High impacting FSD Pharma Inc. - Class B Subordinate Voting Shares news events
Weekly update
A roundup of the hottest topics
HUGE
News
- FSD Pharma Provides Update from Celly Nu’s Partnership with Six+One for unbuzzd(TM)Accesswire
- FSD Pharma Provides Another Update on Celly Nu's Anticipated Launch of unbuzzd(TM) [Yahoo! Finance]Yahoo! Finance
- FSD Pharma Provides Another Update on Celly Nu's Anticipated Launch of unbuzzd(TM)Accesswire
- FSD Pharma Expands Investigative Pipeline to Include Potential Weight Loss and Liver Health Formulations and Products [Yahoo! Finance]Yahoo! Finance
- FSD Pharma Expands Investigative Pipeline to Include Potential Weight Loss and Liver Health Formulations and ProductsAccesswire
HUGE
Sec Filings
- 4/25/24 - Form 6-K
- 4/22/24 - Form 6-K
- 4/17/24 - Form 6-K
- HUGE's page on the SEC website